Bone morphogenic protein-7 contributes to cerebral ischemic preconditioning induced-ischemic tolerance by activating p38 mitogen-activated protein kinase signaling pathway

Inflammation

Volumn 37, Issue 4, 2014, Pages 1289-1296

  Guan, Junhong ^a   Li, Han ^a   Lv, Tao ^a   Chen, Duo ^a   Yuan, Ye ^a   Qu, Shengtao ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

BMP 7; cerebral ischemia reperfusion; ischemic preconditioning; ischemic tolerance; p38 MAPK

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; MITOGEN ACTIVATED PROTEIN KINASE P38; NOGGIN; OSTEOGENIC PROTEIN 1; RECOMBINANT OSTEOGENIC PROTEIN 1; BMP7 PROTEIN, RAT; IMIDAZOLE DERIVATIVE; PYRIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION SIZE; CONTROLLED STUDY; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; ISCHEMIC PRECONDITIONING; ISCHEMIC PRECONDITIONING INDUCED ISCHEMIC TOLERANCE; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PREMEDICATION; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; REPERFUSION INJURY; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; BRAIN; BRAIN ISCHEMIA; CEREBRAL ARTERY DISEASE; CHEMISTRY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHOSPHORYLATION; PROCEDURES; WISTAR RAT;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

ANIMALS; BONE MORPHOGENETIC PROTEIN 7; BRAIN; BRAIN ISCHEMIA; IMIDAZOLES; INFARCTION, MIDDLE CEREBRAL ARTERY; ISCHEMIC PRECONDITIONING; MALE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PYRIDINES; RATS; RATS, WISTAR; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

EID: 84904751894     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-014-9856-7     Document Type: Article

References (33)

1. Jiang, B., W.Z. Wang, H. Chen, Z. Hong, Q.D. Yang, S.P. Wu, X.L. Du, and Q.J. Bao. 2006. Incidence and trends of stroke and its subtypes in China: results from three large cities. Stroke 37: 63-68. (Pubitemid 43732049)
2. Guo, J.M., A.J. Liu, and D.F. Su. 2010. Genetics of stroke. Acta Pharmacologica Sinica 31: 1055-1064.
3. Donnan, G.A., M. Fisher, M. Macleod, and S.M. Davis. 2008. Stroke. Lancet 371: 1612-1623. (Pubitemid 351626845)
4. Gibson, C.L. 2013. Cerebral ischemic stroke: is gender important? Journal of Cerebral Blood Flow and Metabolism 33: 1355-1361.
5. Sacco, R.L., and J.K. Liao. 2005. Drug insight: statins and stroke. Nature Clinical Practice Cardiovascular Medicine 2: 576-584. (Pubitemid 41655661)
6. Johansen, F.F., H. Hasseldam, R.S. Rasmussen, A.S. Bisgaard, P.K. Bonfils, S.S. Poulsen, and J. Hansen-Schwartz. 2014. Drug-induced hypothermia as beneficial treatment before and after cerebral ischemia. Pathobiology 81: 42-52.
7. Iadecola, C., and J. Anrather. 2011. Stroke research at a crossroad: asking the brain for directions. Nature Neuroscience 14: 1363-1368.
8. Dirnagl, U., K. Becker, and A. Meisel. 2009. Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use. Lancet Neurology 8: 398-412.
9. Kirino, T. 2002. Ischemic tolerance. Journal of Cerebral Blood Flow and Metabolism 22: 1283-1296. (Pubitemid 35285085)
10. Kang, Y., W.M. Liao, Z.H. Yuan, P.Y. Sheng, L.J. Zhang, X.W. Yuan, and L. Lei. 2007. In vitro and in vivo induction of bone formation based on adeno-associated virus-mediated BMP-7 gene therapy using human adipose-derived mesenchymal stem cells. Acta Pharmacologica Sinica 28: 839-849. (Pubitemid 46817445)
11. Radhakrishnan, R.S., G.L. Radhakrishnan, H.R. Radhakrishnan, H. Xue, S.D. Adams, S.D. Moore-Olufemi, M.T. Harting, C.S. Cox Jr., and B.C. Kone. 2008. Pretreatment with bone morphogenetic protein-7 (BMP-7) mimics ischemia preconditioning following intestinal ischemia/reperfusion injury in the intestine and liver. Shock 30: 532-536.
12. Guan, J., H. Li, T. Lv, D. Chen, Y. Yuan, and S. Qu. 2013. Bone morphogenetic protein-7 (BMP-7) mediates ischemic preconditioning-induced ischemic tolerance via attenuating apoptosis in rat brain. Biochemical and Biophysical Research Communications 441: 560-566.
13. Roux, P.P., and J. Blenis. 2004. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiology and Molecular Biology Reviews 68: 320-344. (Pubitemid 38756868)
14. Zarubin, T., and J. Han. 2005. Activation and signaling of the p38 MAP kinase pathway. Cell Research 15: 11-18. (Pubitemid 41653958)
15. Ono, K., and J. Han. 2000. The p38 signal transduction pathway: activation and function. Cellular Signalling 12: 1-13. (Pubitemid 30017963)
16. Hu, M.C., D. Wasserman, S. Hartwig, and N.D. Rosenblum. 2004. p38 MAPK acts in the BMP7-dependent stimulatory pathway during epithelial cell morphogenesis and is regulated by Smad1. Journal of Biological Chemistry 279: 12051-12059. (Pubitemid 38445767)
17. Motazed, R., P. Colville-Nash, J.T. Kwan, and M.E. Dockrell. 2008. BMP-7 and proximal tubule epithelial cells: activation of multiple signaling pathways reveals a novel anti-fibrotic mechanism. Pharmaceutical Research 25: 2440-2446.
18. Takahashi, M., F. Otsuka, T. Miyoshi, H. Otani, J. Goto, M. Yamashita, T. Ogura, H. Makino, and H. Doihara. 2008. Bone morphogenetic protein 6 (BMP6) and BMP7 inhibit estrogen-induced proliferation of breast cancer cells by suppressing p38 mitogen-activated protein kinase activation. Journal of Endocrinology 199: 445-455.
19. Elshaier, A.M., A.A. Hakimiyan, L. Rappoport, D.C. Rueger, and S. Chubinskaya. 2009. Effect of interleukin-1beta on osteogenic protein 1-induced signaling in adult human articular chondrocytes. Arthritis & Rheumatism 60: 143-154.
20. Nishimura, M., T. Sugino, K. Nozaki, Y. Takagi, I. Hattori, J. Hayashi, N. Hashimoto, T. Moriguchi, and E. Nishida. 2003. Activation of p38 kinase in the gerbil hippocampus showing ischemic tolerance. Journal of Cerebral Blood Flow and Metabolism 23: 1052-1059. (Pubitemid 37082430)
21. Li, W., Y. Luo, F. Zhang, A.P. Signore, G.T. Gobbel, R.P. Simon, and J. Chen. 2006. Ischemic preconditioning in the rat brain enhances the repair of endogenous oxidative DNA damage by activating the base-excision repair pathway. Journal of Cerebral Blood Flow and Metabolism 26: 181-198. (Pubitemid 43151575)
22. Barancik, M., V. Bohacova, J. Kvackajova, S. Hudecova, O. Krizanova, and A. Breier. 2001. SB203580, a specific inhibitor of p38-MAPK pathway, is a new reversal agent of P-glycoprotein-mediated multidrug resistance. European Journal of Pharmaceutical Sciences 14: 29-36. (Pubitemid 32655412)
23. Groppe, J., J. Greenwald, E. Wiater, J. Rodriguez-Leon, A.N. Economides, W. Kwiatkowski, M. Affolter, W.W. Vale, J.C. Izpisua Belmonte, and S. Choe. 2002. Structural basis of BMP signalling inhibition by the cystine knot protein Noggin. Nature 420: 636-642. (Pubitemid 36764490)
24. Kato, H., Y. Liu, T. Araki, and K. Kogure. 1991. Temporal profile of the effects of pretreatment with brief cerebral ischemia on the neuronal damage following secondary ischemic insult in the gerbil: cumulative damage and protective effects. Brain Research 553: 238-242.
25. Gong, S.J., L.Y. Chen, M. Zhang, J.X. Gong, Y.X. Ma, J.M. Zhang, Y.J. Wang, Y.Y. Hu, X.C. Sun, W.B. Li, and Y. Zhang. 2012. Intermittent hypobaric hypoxia preconditioning induced brain ischemic tolerance by up-regulating glial glutamate transporter-1 in rats. Neurochemical Research 37: 527-537.
26. Lin, T.N., Y.Y. He, G. Wu, M. Khan, and C.Y. Hsu. 1993. Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke 24: 117-121. (Pubitemid 23014393)
27. Wagner, D.O., C. Sieber, R. Bhushan, J.H. Borgermann, D. Graf, and P. Knaus. 2010. BMPs: from bone to body morphogenetic proteins. Science Signaling 3:mr1.
28. Marais, E., S. Genade, B. Huisamen, J.G. Strijdom, J.A. Moolman, and A. Lochner. 2001. Activation of p38 MAPK induced by a multicycle ischaemic preconditioning protocol is associated with attenuated p38 MAPK activity during sustained ischaemia and reperfusion. J Journal of Molecular and Cellular Cardiology 33: 769-778. (Pubitemid 32538989)
29. Dreixler, J.C., F.C. Barone, A.R. Shaikh, E. Du, and S. Roth. 2009. Mitogen-activated protein kinase p38alpha and retinal ischemic preconditioning. Experimental Eye Research 89: 782-790.
30. Weinbrenner, C., G.S. Liu, M.V. Cohen, and J.M. Downey. 1997. Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart. Journal of Molecular and Cellular Cardiology 29: 2383-2391. (Pubitemid 27404431)
31. Saurin, A.T., J.L. Martin, R.J. Heads, C. Foley, J.W. Mockridge, M.J. Wright, Y. Wang, and M.S. Marber. 2000. The role of differential activation of p38-mitogen-activated protein kinase in preconditioned ventricular myocytes. FASEB Journal 14: 2237-2246.
32. Kobayashi, M., I. Takeyoshi, D. Yoshinari, K. Matsumoto, and Y. Morishita. 2002. P38 mitogen-activated protein kinase inhibition attenuates ischemia-reperfusion injury of the rat liver. Surgery 131: 344-349. (Pubitemid 34229789)
33. Lin, S.Z., B.J. Hoffer, P. Kaplan, and Y. Wang. 1999. Osteogenic protein-1 protects against cerebral infarction induced by MCA ligation in adult rats. Stroke 30: 126-133. (Pubitemid 29029453)